Conference Schedule
ADVANCES IN PRECISION MEDICINE: CANCER GENOMICS
Columbia Precision Medicine Initiative Second Annual Conference
8:30 a.m. Registration; Coffee and light breakfast
9:00 a.m. Tom Maniatis, PhD, Columbia University: Welcome
9:05 a.m. Cory T. Abate-Shen, PhD, Columbia University: Introduction
Session 1
9:15 a.m. Arnold J. Levine, PhD, Institute for Advanced Study
The role of inherited p53 mutations in cancers
9:50 a.m. Charles L. Sawyers, MD, Memorial Sloan Kettering Cancer Center
Overcoming cancer drug resistance
10:25 a.m. Arul Chinnaiyan, MD, PhD, Michigan Center for Translational Pathology
The application of integrative sequencing for precision oncology
11:00 a.m. Coffee break
Session 2
11:30 a.m. Catherine J. Wu, MD, Dana-Farber Cancer Institute
Clonal heterogeneity and clonal kinetics in chronic lymphocytic leukemia
12:05 p.m. William C. Hahn, MD, PhD, Dana-Farber Cancer Institute
Genomics, cancer dependencies, and precision medicine
12:40 p.m. Serena Nik-Zainal, MD, PhD, University of Cambridge
Utilizing mutational signatures for clinical purposes
1:15 p.m. Lunch: Faculty Club, P&S Building, 4th Floor
Session 3
2:30 p.m. Nitzan Rosenfeld, PhD, University of Cambridge
Liquid biopsies: monitoring cancer and its genome with circulating tumor DNA
3:05 p.m. Luis A. Diaz, MD, Memorial Sloan Kettering Cancer Center
Somatic mutations as targets for cancer diagnosis and therapy
3:40 p.m. David Tuveson, PhD, Cold Spring Harbor Laboratory
Personalizing the care of pancreatic cancer patients to chemotherapy
4:15 p.m. Raul Rabadan, PhD, Columbia University
Clonal heterogeneity and evolution of brain tumors
4:50 p.m. Reception: Faculty Club, P&S Building, 4th Floor
